Tokyo, Oct. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063313) titled 'Study of Historical changes in treatment for patients with Inflammatory Bowel Disease: SHIFT-IBD' on Oct. 16.
Study Type:
Observational
Primary Sponsor:
Institute - EA Pharma Co., Ltd.
Condition:
Condition - Crohn's disease, Ulcerative colitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to clarify changes in the use of IBD treatments, with a focus on Advanced Therapies (AT), in Japan.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patie...